FagronARSUF -1.74%92 FCF Margin % is 18.36% as of Dec. 2025, which is 49% above its 10-year median of 12.36. GuruFocus rates ARSUF with a GF Score™ of 92/100 and a GF Value™ of $25.96. The stock has 6 warning signs investors should review. Among 958 Drug Manufacturers companies, Fagron ranks better than 77.14% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Fagron's Free Cash Flow for the
six
months ended in Dec. 2025 was $102 Mil. Fagron's Revenue for the
six
months ended in Dec. 2025 was $557 Mil. Therefore, Fagron's FCF Margin % for the quarter that ended in Dec. 2025 was 18.36%.
The historical rank and industry rank for Fagron's FCF Margin % or its related term are showing as below:
ARSUF'
s FCF Margin % Range Over the Past 10 Years
Min: 7.92 Med: 12.36 Max: 17.12
Current: 13.13
During the past 13 years, the highest FCF Margin % of Fagron was 17.12%. The lowest was 7.92%. And the median was 12.36%.
ARSUF's FCF Margin % is ranked better than 77.14% of 958
companies
in the Drug Manufacturers industry
Industry Median: 2.445
vs ARSUF: 13.13
Fagron FCF Margin % Related Terms
Fagron FCF Margin % Historical Data
* Premium members only.
The historical data trend for Fagron's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Fagron's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fagron FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Fagron's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Fagron's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fagron (ARSUF) has a FCF Margin % of 18.36% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fagron and its competitors. This is 49% above median its historical median of 12.36. Over the past decade, Fagron's FCF Margin % has ranged from 7.92 to 17.12. According to the industry distribution chart, Fagron ranks #219 out of 958 companies in the Drug Manufacturers industry, placing it in the top 22.9%.
Is Fagron's FCF Margin % too high?
Fagron's current FCF Margin % of 18.36% is 49% above median its 10-year median of 12.36. Over the past 10 years, this metric has ranged from a low of 7.92 to a high of 17.12. The Drug Manufacturers industry median FCF Margin % is 2.45. Fagron's value of 18.36% is 650.9% above this industry median. Based on the distribution chart, Fagron ranks #219 out of 958 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Fagron has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Fagron's FCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Fagron ranks #219 out of 958 companies for FCF Margin %. This places Fagron in the top 23% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.45. Fagron's value of 18.36% is 650.9% above this benchmark. Historically, Fagron's own FCF Margin % has ranged from 7.92 to 17.12 over the past decade. While the company's 10-year median is 12.36 vs. the industry median of 2.45, Fagron has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.45, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fagron's current FCF Margin % of 18.36% is 650.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Fagron and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fagron's current FCF Margin % is 18.36%, which is 49% above median its own 10-year median of 12.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fagron stock overvalued right now?
Fagron (ARSUF) has a current FCF Margin % of 18.36%. The stock's GF Value™ is $25.96, compared to a current price of $26.53 — trading 2.2% above its estimated fair value. The current FCF Margin % is 18.36%, which is 49% above median its 10-year median of 12.36 and 650.9% above the Drug Manufacturers industry median of 2.45. Fagron's overall GF Score™ is 92/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Fagron (ARSUF), the current FCF Margin % is 18.36% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fagron (ARSUF) Overvalued in 2026?
Based on GuruFocus' analysis, Fagron stock appears to be overvalued.
The current stock price of $26.53 is trading 2.2% above its estimated GF Value™ of $25.96.
Key valuation signals for ARSUF:
FCF Margin %: 18.36% (49% above median its 10-year median of 12.36)
GF Value™: $25.96 vs. price of $26.53 (2.2% above fair value)
Industry Position: 650.9% above the Drug Manufacturers median (#219 of 958)
No single metric tells the full story. See the ARSUF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fagron SA is a Belgium-based multinational pharmaceutical compounding company specializing in pharmaceutical compounding. It operates across the pharmaceutical compounding value chain, developing and manufacturing personalized medicines in collaboration with pharmacists, prescribers, hospitals, and other healthcare providers. The company has three segments: Essentials, Brands, and Compounding Services. The majority of the revenue is derived from the Essentials segment, which provides raw materials, equipment, packaging, and supplies for compounding to pharmacies and healthcare industries across EMEA, Latin America, and North America - Pacific. Geographically, it generates the maximum revenue from Fagron North America - Pacific.
92GF Score
Get the complete analysis for ARSUF
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARSUF has been successfully added to your 
